Navigation Links
Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
Date:7/22/2013

plex cystic fibrosis assay, the first respiratory viral panel and most recently the first gastrointestinal pathogen panel. Luminex's portfolio of multiplexing instruments and assays addresses a broad range of laboratory and budgetary needs for life science research, clinical diagnostics, and biosurveillance.  The instrument line includes the 100-plex Luminex 100/200, the economical 50-plex MAGPIX and the high-throughput, 500-plex FLEXMAP 3D® systems.

Rhode Island Hospital is the principal teaching hospital of The Warren Alpert Medical School of Brown University.

About Luminex Corporation

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com/.

Contacts:

Luminex Investor Contact:
Matthew Scalo, 512.219.8020
Sr. Director Investor Relations
mscalo@luminexcorp.com

'/>"/>
SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Luminex Corporation Second Quarter Earnings Release Scheduled for July 29, 2013
2. Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporations xMAP Technology
3. Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
4. Luminex Corporation To Present At Upcoming Investment Conferences
5. Luminex Corporation Reports First Quarter 2013 Results
6. Luminex Corporation First Quarter Earnings Release Scheduled for April 29, 2013
7. Luminex Corporation Reports Fourth Quarter And Full Year 2012 Results
8. Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
9. Luminex Corporation Reports Third Quarter 2012 Results
10. Luminex Corporation To Present At Upcoming Investment Conferences In September
11. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015 CANTEL MEDICAL CORP. (NYSE: CMN ) ... Officer, will be presenting at the Bank of America Merrill ... in Las Vegas, NV. The formal ... AM PT/1:00 PM ET. In addition, management will be available ... An audio webcast will be available via the investor relations ...
(Date:5/1/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/pjbxjd/us_aco_it ... ACO IT Spending Outlook 2018" report to their ... lives covered by ACO would grow at a CAGR ... ACO IT spending has been studied on three main ... spending on services. Our research provides current market estimation ...
(Date:5/1/2015)... -- CytRx Corporation (CYTR), a biopharmaceutical research and development ... for the three months ended March 31, 2015, ... upcoming milestones for its clinical development programs. ... months of 2015, including the announcement of encouraging ... patients with soft tissue sarcoma, and positive interim ...
Breaking Medicine Technology:United States ACO IT Spending Outlook 2014-2018 2CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11
... 2011  Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) ... of its European marketing authorization application ("MAA") for Pixuvri. ... the E.U. for patients with relapsed or refractory aggressive ... prior lines of therapy. CTI received the CHMP,s day ...
... 2, 2011 Shire plc (LSE: SHP, NASDAQ: ... that it has reached an agreement with the Center ... Food and Drug Administration (FDA) to conduct additional clinical ... HCl), a medicine approved in 1996 under Subpart H ...
Cached Medicine Technology:European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 2European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 3European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 4European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 5ProAmatine® (midodrine HCl) Update: Path Forward Agreed 2ProAmatine® (midodrine HCl) Update: Path Forward Agreed 3ProAmatine® (midodrine HCl) Update: Path Forward Agreed 4
(Date:5/2/2015)... 02, 2015 ZoomCare, the Portland-based innovator ... plans to offer its new healthcare insurance to individuals ... Personal Health Insurance System is the nation’s first health ... human performance. ZOOM+ Personal Health Insurance was ZoomCare’s first ... that are subject to review and regulation by the ...
(Date:5/1/2015)... IDLife LLC, a health and wellness ... the addition of its newest partner and fitness celebrity, ... athlete, growing up in gymnastics and competitive diving, but ... a personal trainer and helping others achieve their fitness ... TV shows highlighting her stunning physique and unique training ...
(Date:5/1/2015)... 01, 2015 Pioneer Millworks, the largest ... latest in their reclaimed wood products at the 27th ... Javits Center in NYC this May. Their newest offerings, ... much anticipated texture and color to North America's platform ... of texture and color in the design world and ...
(Date:5/1/2015)... ME (PRWEB) May 01, 2015 Royal ... in Freeport, Maine, reports on a new study that ... stiffness, joint swelling and improved physical function as well ... with severe osteoarthritis of the knee. , The report ... Natural Insights for Well Being® ,” which Royal River ...
(Date:5/1/2015)... 01, 2015 TROY Healthcare Solutions is ... Regional User Group (RUG) Conference in Atlanta, GA from ... User Group Conference provides a forum for client-to-client presentations, ... all aspects of electronic medical record operations, as well ... applications. , In addition to sponsoring the event, TROY ...
Breaking Medicine News(10 mins):Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3
... by using genetic material ,called targeting RNA, to enter ... to stop the expression of a protein that keeps ... normal cells ,unharmed. ,The drug, developed at ... material, called In tests in mice with prostate cancer, ...
... the final day of the Eighth International Conference on ... released in which it was noted that Mercury pollution// ... everywhere from industrial sites to remote corners of the ... those threats. ,"The declaration essentially says that ...
... of twins, much in contrast with the delivery timing for ... risks if twins are delivered after 40 weeks, new research ... delivery. ,A University of Ottawa, Canada research ... was between 38 and 39 weeks. This does not compare ...
... August 13 in Nature Genetics by researchers at the ... says that there// are many more causes of mental ... large deletion in six genes on chromosome 17. The ... and other physical features that are identical to several ...
... that even in young neurons it is the survival of ... off// depends on its ability to establish connections with other ... Fred H. Gage, Ph.D., a professor in the Gene Expression ... on Age-Related Neurodegenerative Diseases. It says that a subunit of ...
... others are being sought for a joint study being ... of a// collaborative effort to better understand the genetics ... form of cancer in men. ,Cedars-Sinai Medical ... Oschin Comprehensive Cancer Institute in Los Angeles is seeking ...
Cached Medicine News:Health News:Dangers Of Mercury 2Health News:Genetics Of Mental Retardation 2Health News:Fittest Of Newborn Neurons Survive 2Health News:Fittest Of Newborn Neurons Survive 3Health News:Prostate Cancer Patients Sought for Database as Part of Joint Effort 2Health News:Prostate Cancer Patients Sought for Database as Part of Joint Effort 3
Make better prescribing decisions with this drug interaction analyzer containing over 3,000 brand names with generic equivalents....
... Guide for Physicians - ... Integrated Calculators - combines ... and practical drug resource ... dosing calculation tools for ...
AnesthesiaDrugs™ is the handheld version of Sota Omoigui's Anesthesia Drugs Handbook, the best selling clinical guide to essential anesthesia and critical care drug information....
... drug information reference that integrates ... patient care guidelines., The sixth ... 4,700 drugs, including the latest ... indications, dosages, side effects and ...
Medicine Products: